Discussion 2
Pharmacokinetics describes what the body does to the drug through absorption, distribution,
metabolism, and excretion, whereas pharmacodynamics describes what the drug does to the
body.
When selecting drugs and determining dosages for patients, it is essential to consider individual
patient factors that might impact the patient’s pharmacokinetic and pharmacodynamic
processes. These patient factors include genetics, gender, ethnicity, age, behavior (i.e., diet,
nutrition, smoking, alcohol, illicit drug abuse), and/or pathophysiological changes due to
disease.
For this Discussion, you reflect on a case from your past clinical experiences and consider how
a patient’s pharmacokinetic and pharmacodynamic processes may alter his or her response to a
drug.
To Prepare
· Review the Resources for this module and consider the principles of pharmacokinetics
and pharmacodynamics.
· Reflect on your experiences, observations, and/or clinical practices from the last 5
years and think about how pharmacokinetic and pharmacodynamic factors altered his or
her anticipated response to a drug.
· Consider factors that might have influenced the patient’s pharmacokinetic and
pharmacodynamic processes, such as genetics (including pharmacogenetics), gender,
ethnicity, age, behavior, and/or possible pathophysiological changes due to disease.
· Think about a personalized plan of care based on these influencing factors and patient
history in your case study.
1. Can you describe a specific case from your past clinical experiences where a patient's
pharmacokinetic processes affected their response to a drug?
2. What were the key pharmacokinetic factors that influenced the patient's drug response in
that case?
3. How did the patient's age, weight, and body composition impact the pharmacokinetics of the
drug?
For this Discussion, you reflect on a case from your past clinical experiences and
consider how a patient’s pharmacokinetic and pharmacodynamic processes may alter
his or her response to a drug.
In one of my past clinical experiences, I encountered a case involving an elderly patient who was
prescribed a medication for hypertension. This patient, let's call her Mrs. Smith, was in her late 70s and
had a history of several chronic conditions, including hypertension, diabetes, and kidney disease.
When considering Mrs. Smith's pharmacokinetic processes, there were several factors that could have
influenced her response to the prescribed medication. Firstly, her age is an important consideration. As
individuals age, physiological changes occur that can affect drug absorption, distribution, metabolism,
and excretion. For example, there may be a decrease in gastric acid secretion and gastrointestinal
motility, which can impact drug absorption. Additionally, changes in liver and kidney function can affect
drug metabolism and excretion, respectively.
Furthermore, Mrs. Smith's pathophysiological changes due to her comorbidities, such as kidney disease,
may have altered her pharmacokinetic processes. Kidney disease can impair renal function, leading to a
decreased clearance of drugs and potentially resulting in drug accumulation. This may require dosage
adjustments to avoid drug toxicity.
In terms of pharmacodynamics, Mrs. Smith's individual patient factors could also influence her response
to the medication. Genetics can play a role in drug response, as certain genetic variations can affect drug
metabolism or drug receptor interactions. Additionally, her comorbidities, particularly diabetes, could
have an impact on how the medication works in her body. For example, certain antihypertensive
medications may have different effects on blood glucose levels, which would need to be monitored
